The treatment of WHO Category 1 tuberculosis with 2HRZE/6HE is indeed defensible.
Mathew
R
R
Tuberculosis Research Centre, Chennai, India.
Santha
T
T
D000995:Antitubercular Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016896:Treatment Outcome; D016312:Treatment Refusal; D014376:Tuberculosis / Q000145:classification / Q000188:drug therapy*; D014944:World Health Organization
D000995:Antitubercular Agents; D007538:Isoniazid